Idexx Laboratories (IDXX) EPS (Basic) (2009 - 2026)

Idexx Laboratories' EPS (Basic) history runs 18 years deep, the most recent figure standing at $3.5 for Q1 2026.

• In Q1 2026, EPS (Basic) rose 17.45% year-over-year to $3.5; the TTM figure through Mar 2026 stood at $13.7 (up 25.46% YoY), while the FY2025 annual figure was $13.17, up 22.28% from the prior year.
• EPS (Basic) was $3.5 for Q1 2026 at Idexx Laboratories, up from $3.11 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $3.66 in Q2 2025 to a low of $1.57 in Q2 2022.
• Historically, EPS (Basic) has averaged $2.69 across 5 years, with a median of $2.65 in 2024.
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) plunged 33.76% in 2022, then jumped 71.97% in 2023.
• A 5-year view of EPS (Basic) shows it stood at $2.08 in 2022, then climbed by 12.5% to $2.34 in 2023, then grew by 13.25% to $2.65 in 2024, then climbed by 17.36% to $3.11 in 2025, then advanced by 12.54% to $3.5 in 2026.
• The last three EPS (Basic) figures came in at $3.5 (Q1 2026), $3.11 (Q4 2025), and $3.43 (Q3 2025), per Business Quant data.